The selected examples are diminished haptoglobin values in hepatocellular carcinoma [327], reduced hemopexin levels in prostate cancer patients [299], and downregulated ceruloplasmin in adrenocortical and hepatocellular carcinomas [328,329]. Here, HPX is linked to hepatocellular carcinoma.